lifetriada.blogg.se - Capto l resin

C07K1/113- General methods for the preparation of peptides, i.e.processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides C07K1/107- General methods for the preparation of peptides, i.e.processes for the organic chemical preparation of peptides or proteins of any length C07K1/00- General methods for the preparation of peptides, i.e.A61P27/00- Drugs for disorders of the senses.A61P19/02- Drugs for skeletal disorders for joint disorders, e.g.A61P19/00- Drugs for skeletal disorders.

A61P17/00- Drugs for dermatological disorders.

A61P- SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS.

A61K38/1866- Vascular endothelial growth factor.

A61K38/1858- Platelet-derived growth factor.

A61K38/18- Growth factors Growth regulators.

A61K38/179- Receptors Cell surface antigens Cell surface determinants for growth factors for growth regulators.

A61K38/177- Receptors Cell surface antigens Cell surface determinants.

A61K38/17- Peptides having more than 20 amino acids Gastrins Somatostatins Melanotropins Derivatives thereof from animals from humans.

A61K38/16- Peptides having more than 20 amino acids Gastrins Somatostatins Melanotropins Derivatives thereof.

A61K38/00- Medicinal preparations containing peptides.

A61K- PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES.

A61- MEDICAL OR VETERINARY SCIENCE HYGIENE.

C07K14/71- Receptors Cell surface antigens Cell surface determinants for growth factors for growth regulators.

C07K14/705- Receptors Cell surface antigens Cell surface determinants.

C07K14/435- Peptides having more than 20 amino acids Gastrins Somatostatins Melanotropins Derivatives thereof from animals from humans.

C07K14/00- Peptides having more than 20 amino acids Gastrins Somatostatins Melanotropins Derivatives thereof.

monoclonal or polyclonal antibodies against material from animals or humans against growth factors against growth regulators

monoclonal or polyclonal antibodies against material from animals or humans Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US201962944635P priority Critical Priority to US202063065012P priority Priority to PCT/US2020/046862 priority patent/WO2021112929A1/en Application filed by Regeneron Pharma filed Critical Regeneron Pharma Publication of IL288351D0 publication Critical patent/IL288351D0/en Links Original Assignee Regeneron Pharma Priority date (The priority date is an assumption and is not a legal conclusion. Google Patents Anti-vegf protein compositions and methods for producing the same Google Patents IL288351D0 - Anti-vegf protein compositions and methods for producing the same IL288351D0 - Anti-vegf protein compositions and methods for producing the same